[go: up one dir, main page]

MX7113E - Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo - Google Patents

Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo

Info

Publication number
MX7113E
MX7113E MX819332U MX933281U MX7113E MX 7113 E MX7113 E MX 7113E MX 819332 U MX819332 U MX 819332U MX 933281 U MX933281 U MX 933281U MX 7113 E MX7113 E MX 7113E
Authority
MX
Mexico
Prior art keywords
blood plasma
compositions containing
cryprecipitate
procedure
containing fibronectin
Prior art date
Application number
MX819332U
Other languages
English (en)
Inventor
Donald G Wallace
Phillip M Schneider
John L Lundblad
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Lab filed Critical Cutter Lab
Publication of MX7113E publication Critical patent/MX7113E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX819332U 1980-03-05 1981-03-05 Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo MX7113E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/127,340 US4341764A (en) 1980-03-05 1980-03-05 Method of preparing fibronectin and antihemophilic factor

Publications (1)

Publication Number Publication Date
MX7113E true MX7113E (es) 1987-06-29

Family

ID=22429606

Family Applications (1)

Application Number Title Priority Date Filing Date
MX819332U MX7113E (es) 1980-03-05 1981-03-05 Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo

Country Status (9)

Country Link
US (1) US4341764A (es)
EP (1) EP0035202B1 (es)
JP (1) JPS56139418A (es)
AT (1) ATE15973T1 (es)
CA (1) CA1164342A (es)
DE (1) DE3172567D1 (es)
DK (1) DK156697C (es)
ES (1) ES500122A0 (es)
MX (1) MX7113E (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS584074U (ja) * 1981-06-30 1983-01-11 井上　岱介 風車ネオン式検電器
EP0076870B1 (en) * 1981-10-12 1985-06-05 Armour Pharmaceutical Company Process for the preparation of highly purified antihemophilic factor
US4391749A (en) * 1981-10-19 1983-07-05 La Jolla Cancer Research Foundation Method for the purification of collagens
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
JPS59134732A (ja) * 1983-01-21 1984-08-02 Green Cross Corp:The フイブロネクチン・生理活性物質複合体の製造法
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
JPS6133124A (ja) * 1983-11-04 1986-02-17 ラルフ　シルヴア−マン 異性々疾患を治療するための培養間葉細胞から抽出した巨大分子
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
AT385658B (de) * 1985-03-28 1988-05-10 Serotherapeutisches Inst Wien Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung
US4587122A (en) * 1985-04-23 1986-05-06 The Green Cross Corporation Fibronectin-dextran-drug complex and method of preparation thereof
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US5453489A (en) * 1992-01-31 1995-09-26 La Jolla Cancer Research Foundation Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
US5629291A (en) * 1992-01-31 1997-05-13 La Jolla Cancer Research Foundation Methods of modulating fibronectin extracellular matrix assembly
US5821220A (en) * 1995-06-07 1998-10-13 Andre Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US6528483B2 (en) * 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
WO1999037680A1 (en) * 1998-01-23 1999-07-29 Csl Limited Purification of fibrinogen
EP2130554B1 (en) 1999-02-22 2012-09-05 University of Connecticut Albumin-free factor VIII formulations
WO2001048016A1 (en) * 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
DE102004044419B4 (de) 2004-09-14 2010-04-15 Biotest Ag Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
WO2010136039A1 (en) 2009-05-25 2010-12-02 H. Lundbeck A/S Preparation of nalmefene hydrochloride from naltrexone
IL213864A0 (en) 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
US8844879B2 (en) * 2011-12-12 2014-09-30 The Boeing Company Wing variable camber trailing edge tip
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma

Also Published As

Publication number Publication date
DE3172567D1 (en) 1985-11-14
EP0035202A2 (en) 1981-09-09
JPS56139418A (en) 1981-10-30
ES8202029A1 (es) 1982-01-01
EP0035202B1 (en) 1985-10-09
DK98581A (da) 1981-09-06
CA1164342A (en) 1984-03-27
ATE15973T1 (de) 1985-10-15
ES500122A0 (es) 1982-01-01
US4341764A (en) 1982-07-27
EP0035202A3 (en) 1982-09-01
DK156697C (da) 1990-02-05
DK156697B (da) 1989-09-25

Similar Documents

Publication Publication Date Title
MX7113E (es) Procedimiento para aislar composiciones que contienen fibronectina,a partir de un crioprecipitado de plasma sanguineo
NO160600C (no) Fremgangsmaate for flytendegjoering av naturgass.
ES522310A0 (es) Un metodo de tratar una composicion sustancialmente seca que incluye factor viii de plasma sanguineo.
ES2046996T3 (es) Procedimiento para purificar organofosfitos terciarios.
NO901665L (no) Fremgangsmaate ved utvinning av naturgass.
ES507559A0 (es) Un metodo de aislar esteroles, particularmente colesterol, en cantidades comerciales, a partir de un material que los contiene.
NZ253294A (en) Extraction of prothrombin from blood
FI971000A0 (fi) Kantasolujen jakautumista hidastava aine ja sen käyttö
ES483756A1 (es) Un procedimiento para la preparacion de 1-(p-metoxibenzoil) -2- pirrolidinona
ATE77637T1 (de) Antioxidationszusammensetzungen und verfahren zu ihrer verwendung.
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
ES2095068T3 (es) Peroxicarbonatos polimericos y procedimiento para prepararlos.
ATE7011T1 (de) Verfahren zur herstellung von wasserstoffperoxid.
DE3174509D1 (en) Glutathione peroxidase, process for production thereof, method and composition for the quantitative determination of lipid peroxide
DK151273C (da) Fremgangsmaade til fremstilling af cholesterolbiosynteseinhibitoren mb- 530a.
NO155916C (no) Fremgangsmaate ved utfoerelse av en eksoterm, nikkel-katalysert metaneringsreaksjon.
IE810873L (en) Fluorene derivatives.
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
NO158549C (no) Fremgangsmaate for avsverting av sverteholdige sekundaere fiberkilder.
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
NO863472D0 (no) Fremgangsmaate for konvertering av naturgass.
DE3869885D1 (de) Verfahren zur herstellung des gereinigten naphthalin-2,6-dicarbonsaeure-bis (2-hydroxyethyl)-esters.
ES8404183A1 (es) Un procedimiento para la preparacion de composiciones farmaceuticas orales de acido propionhidroxamico.
MX158726A (es) Un procedimiento para la preparacion de gases que contienen hidrogeno
DE3160828D1 (en) Process for the manufacture of methane-containing gas from ethanol